Table 1. Serial representation of clinical course, peritoneal findings, and therapy over 9 months in a peritoneal dialysis patient with protracted pseudomonas peritonitis complicated by rind formation.

Date	Clinical presentation	Culture/sensitivity of peritoneal fluid effluents	Cell counts (/mm3) from peritoneal fluids
7/3/11	Peritonitis – abdominal pain T-96.7°	Pseudomonas aeruginosa Tobra, Levo, Ceftaz*	PD-5.68k; WBC-16.1k (Figure 1)
7/17/11	Peritonitis – pain/nausea/vomiting T-98.4° BP-186/90	Pseudomonas aeruginosa Tobra, Levo*	PD-4.23k; WBC-51.0k
7/21/11	PD Cath out
11/7/11	Peritonitis Abscess drained – blood-tinged clear straw-colored fluid	Pseudomonas aeruginosa Tobra, Levo, Ceftaz	PD-1.83k; WBC-8.9k
11/23/11	Abdominal pain T-98.5° BP-215/110 abscess drained – blood-tinged straw-colored fluid	Pseudomonas aeruginosa Tobra, Levo, Ceftaz*	WBC-12.9k (Figure 2)
12/6/11	Right lower quadrant pain T-98.4°	Pseudomonas aeruginosa Tobra, Levo, Ceftaz
2/29/12	Follow-up Peri-hepatic fluid drained – clear, light brown fluid	No growth 5 days	WBC-11.7k (Figure 3)
4/11/12	Follow-up Peri-hepatic fluid drained – clear, yellow fluid	No growth 5 days	PD-53; WBC-20.7k (Figure 4)

*Abbreviations for tobramycin, levofloxacin, & ceftazidime.